Phase I study of LY2469298, an Fc-engineered humanized anti-CD20 antibody, in patients with relapsed or refractory follicular lymphoma.
| Image |  |
|---|---|
| Description | scientific article published on 12 January 2011 |
| Author/s |
author: Kensei Tobinai Yukio Kobayashi |
| Publication date | January 12, 2011 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |